The development of a risk threshold to aid risk stratified approach to monitoring for haematological, hepatic and/or renal adverse drug reactions during established cs DMARD treatment for systemic autoimmune rheumatic diseases: a RAND/UCLA Appropriat
A threshold to aid risk-stratified monitoring during established csDMARD treatment was agreed for adults with SARD.
Authors
- Samantha Hider (ORCID: https://orcid.org/0000-0002-9958-3909)
- Nicola Gullick (ORCID: https://orcid.org/0000-0001-8970-4116)
- Amy Foulkes (ORCID: https://orcid.org/0000-0003-2680-750X)
- Julia S. Holmes
- Kate Parsons
- Su Yin Tan
- R. Heaton
- John A. Reynolds (ORCID: https://orcid.org/0000-0002-8962-4404)
- Georgina Nakafero (ORCID: https://orcid.org/0000-0002-3859-7354)
- Stuart Kyle (ORCID: https://orcid.org/0000-0001-9837-6863)
- Hope De Vere
- Louise Mercer (ORCID: https://orcid.org/0009-0007-2108-3393)
- Abhishek Abhishek (ORCID: https://orcid.org/0000-0003-0121-4919)
- Alison Ahmed
- Natasha Wood
- Emmandeep Dhillon
- Abdullah Almayahi
- Sarah J Ryan
- James Galloway
- Alan Davidson
- Genevieve Zebate
- Joanne Ablewhite
- Kataryzna Nowak
- Katie Bechman
- Helen Twohigg
Institutions
- Belfast Health and Social Care Trust (GB)
- North Bristol NHS Trust (GB)
- NHS Lothian (GB)
- Nottingham University Hospitals NHS Trust (GB)
- King's College London (GB)
- North Devon District Hospital (GB)
- New Cross Hospital (GB)
- Western General Hospital (GB)
- Birmingham Community Healthcare NHS Trust (GB)
- Volunteer State Community College (US)
- Salford Royal NHS Foundation Trust (GB)
- University Hospital Coventry (GB)
- Gloucestershire Hospitals NHS Foundation Trust (GB)
- Stepping Hill Hospital (GB)
- University Hospitals Coventry and Warwickshire NHS Trust (GB)
- Nottingham City Hospital (GB)
- University of Warwick (GB)
- Institut thématique Immunologie, inflammation, infectiologie et microbiologie (FR)
- Tameside and Glossop Integrated Care NHS Foundation Trust (GB)
- Barlow Medical Centre (GB)
- Midlands Partnership NHS Foundation Trust (GB)
- Boehringer Ingelheim (South Korea) (KR)
- Centre for Inflammation Research (GB)
- Keele University (GB)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1093/rheumatology/keag031
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00